Oncology & Cancer

New targets in the fight against pancreatic cancer

Pancreatic cancer remains one of the deadliest malignancies worldwide. Since five-year survival rate for pancreatic ductal adenocarcinoma (PDAC) is only about 3% in patients, PDAC is very difficult to treat with surgery worldwide. ...

Diseases, Conditions, Syndromes

Andromeda Biotech: A drug for type 1 diabetes

The treated patients in the double-blinded study of DiaPep 277 showed significantly better pancreas function that the control group.

page 4 from 12